KBC Group’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40K Hold
895
﹤0.01% 1771
2026
Q1
$46K Hold
895
﹤0.01% 1678
2025
Q4
$83K Hold
895
﹤0.01% 1404
2025
Q3
$66K Hold
895
﹤0.01% 1520
2025
Q2
$116K Sell
895
-476
-35% -$69K ﹤0.01% 1108
2025
Q1
$218K Buy
1,371
+46
+3% +$8.32K ﹤0.01% 1021
2024
Q4
$246K Buy
1,325
+455
+52% +$88.3K ﹤0.01% 1022
2024
Q3
$184K Buy
870
+126
+17% +$21.9K ﹤0.01% 977
2024
Q2
$100K Buy
744
+84
+13% +$15.9K ﹤0.01% 1162
2024
Q1
$142K Buy
660
+88
+15% +$17.3K ﹤0.01% 969
2023
Q4
$116K Hold
572
﹤0.01% 1000
2023
Q3
$114K Buy
+572
New +$144K ﹤0.01% 961

Other funds holding INSP

KBC Group's INSP Position: Q2 2026 in Review

KBC Group held its Inspire Medical Systems (INSP) position steady in Q2 2026 at 895 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #1771.

KBC Group first reported a position in INSP in Q3 2023 and has held it in 12 quarters since. The position peaked at $246K in Q4 2024. 105 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • KBC Group held 895 shares of Inspire Medical Systems worth $40K as of Q2 2026.
  • KBC Group left its Inspire Medical Systems share count unchanged in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1771 holding.
  • KBC Group first reported a position in Inspire Medical Systems in Q3 2023 and has held it in 12 quarters since.
  • KBC Group's Inspire Medical Systems position peaked at $246K in Q4 2024.
  • 105 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.